Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 20;13(4):e12299.
doi: 10.1002/pul2.12299. eCollection 2023 Oct.

Atrial septal defect closure is associated with improved clinical status in patients ≤ 10 kg with bronchopulmonary dysplasia

Affiliations

Atrial septal defect closure is associated with improved clinical status in patients ≤ 10 kg with bronchopulmonary dysplasia

Melissa K Webb et al. Pulm Circ. .

Abstract

Patients with bronchopulmonary dysplasia (BPD) have shown clinical improvement after secundum atrial septal defect (ASD) closure. We sought to determine if this post-ASD closure improvement is secondary to the expected course in BPD patients or related to the closure itself. A novel BPD-ASD score was created to assess patients' clinical status (higher score = worse disease) and applied to 10 BPD-ASD inpatients weighing ≤ 10 kg who underwent ASD closure. The score and its subcomponents were retrospectively calculated serially ranging from 8 weeks pre- to 8 weeks post-intervention, and pre- and post-intervention score slopes were created. These slopes were compared using mixed regression modeling with an interaction term. There was a significant difference in pre- versus post-intervention slope with the most score drop the first week post-intervention (-2.1 + /- 0.8, p = 0.014). The mean score also dropped through weeks 2 (slope -0.8 + /- 0.8, p = 0.013) and 4 (slope -1.0 + /- 0.5, p = 0.001) post-intervention. There was a significant difference in pre- and post-intervention slopes for diuretics (p = 0.018) and the combined score of respiratory support, FiO2 need, and respiratory symptoms (p = 0.018). This study demonstrated significant improvement in BPD-ASD score, diuretic need, and respiratory status after ASD closure in BPD-ASD patients ≤ 10 kg that was outside of the natural course of BPD. Our study was limited by its small, single-center, retrospective nature. Future studies should be performed in a larger multicenter population to both validate the scoring system and compare to non-intervention infants.

Keywords: neonatal lung disease & BPD; pediatrics; pulmonary hypertension.

PubMed Disclaimer

Conflict of interest statement

Dr. Varghese receives royalties as an UptoDate reviewer; receives honoraria from Practice Point Communications as a speaker; receives research support from Janssen Pharmaceutical company; and receives an honoraria from the Pulmonary Hypertension Association for Professional development. Dr. Morris served on the scientific advisory board for Aytu Biopharma for a clinical trial for Vascular Ehlers‐Danlos syndrome until November 2022. Dr. Sexson Tejtel served on the Sobi scientific advisory board in 2022 and was provided a paid trip through the company regarding inflammatory heart conditions. The remaining authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(a) Spaghetti plot showing each individual bronchopulmonary dysplasia (BPD)‐atrial septal defect (ASD) score over time with time “0” marking the intervention, and scores 8 weeks before and 8 weeks after the intervention. (b) A simplified graph, with the only breakpoint at intervention, to allow the analysis of aggregate slopes with 95% confidence limits (regression lines) before and after intervention. This shows that while the pre‐intervention slope was no different than 0, the score post‐intervention was significantly decreasing, and the pre‐ and post‐intervention slopes were significantly different than each other. (c) Graph with slopes and 95% confidence limits before and after intervention, with additional division of time periods post‐intervention to evaluate the speed of change in relationship to intervention timing. Before intervention, the BPD‐ASD score was stable with no change over time. The week after the intervention the score drops an average of 2.2 ± 0.8 points, which is a significant slope change (p = 0.014). The mean score continues to significantly drop through weeks 2 and 4 post‐intervention. After week 4, there is no longer a significant drop in score. *p < 0.05.
Figure 2
Figure 2
Stacked area graphs for each subcomponent of the bronchopulmonary dysplasia (BPD)‐atrial septal defect (ASD) score, showing by shade the proportion of subjects with each subcomponent score. (a) The proportion of patients with high diuretic scores decreases after the intervention. (b) Respiratory score, which is a combination score consisting of the FiO2 need, respiratory support, and respiratory symptoms scores. After the intervention, the majority of the patients had a lower score than before the intervention. (c) Growth score, showing no difference in improvement of growth pre‐ and post‐intervention. (d) Estimated right ventricular (RV) pressure, which shows that after the intervention the majority of patients ultimately had a normal RV pressure.
Figure 3
Figure 3
Regression analysis with 95% interval lines fit for each subcomponent of the bronchopulmonary dysplasia (BPD)‐atrial septal defect (ASD) scoring system was performed with the only breakpoint at the time of intervention. (a) The pre‐intervention diuretic score was not significantly different than a slope of 0. The post‐intervention diuretic score slope was significantly different than a slope of 0 (decreasing) and the post‐intervention score slope was significantly different than the pre‐intervention diuretic score slope (p = 0.018). (b) Respiratory score consisted of the total points assigned for FiO2 need, respiratory symptoms, and respiratory support. The pre‐intervention respiratory score slope was not significantly different than 0. The post‐intervention respiratory score slope was significantly different than 0 (decreasing) and the post‐intervention score slope was significantly different than the pre‐intervention respiratory score slope. (c) The growth score slope was significantly different than 0 (decreasing) for both pre‐ and post‐intervention and there was no significant difference between slope 1 and slope 2. (d) The pre‐intervention estimated RV pressure score slope was no different than 0, but the post‐intervention estimated RV pressure score was significantly different than 0, indicating a significant decrease in estimated RV pressure score. However, there was no difference between pre‐ and post‐intervention slopes. *p ≤ 0.05.

Similar articles

Cited by

References

    1. Mourani PM, Abman SH. Pulmonary hypertension and vascular abnormalities in bronchopulmonary dysplasia. Clin Perinatol. 2015;42:839–855. - PMC - PubMed
    1. Lassus P, Turanlahti M, Heikkilä P, Andersson LC, Nupponen I, Sarnesto A, Andersson S. Pulmonary vascular endothelial growth factor and Flt‐1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med. 2001;164(10Pt1):1981–1987. - PubMed
    1. Kumar H. Growth factors in the fetal and neonatal lung. Front Biosci. 2004;9:464–480. - PubMed
    1. D'Angio T. The role of vascular growth factors in hyperoxia‐induced injury to the developing lung. Front Biosci. 2002;7:d1609–d1623. - PubMed
    1. Thébaud B, Abman SH. Bronchopulmonary dysplasia: where have all the vessels gone? roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med. 2007;175:978–985. - PMC - PubMed